Meningeal lymphomatosis as the first manifestation of splenic marginal zone lymphoma

International Journal of Hematology

Volumn 82, Issue 1, 2005, Pages 63-65

  Bruna, Jordi ^a   Martínez Yelamos, Sergio ^a   Alonso, Esther ^a   Romagosa, Vicente ^a   Arruga, Jordi ^a   Fernández, Susana ^a   Domingo, Alicia ^a   Rojas Marcos, Iñigo ^a   Petit, Josep ^a   Rubio, Francisco ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Meningeal lymphomatosis; Splenic marginal zone lymphoma

Indexed keywords

CORTICOSTEROID; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HUMAN; IMMUNOPHENOTYPING; LYMPHOMA; LYMPHOMATOSIS; MALE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLEDEMA; SPLEEN TUMOR; SPLENECTOMY; SPLENIC MARGINAL ZONE LYMPHOMA; SPLENOMEGALY; TREATMENT OUTCOME; TUMOR DIAGNOSIS; VISUAL IMPAIRMENT;

EID: 27244436405     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.E0501     Document Type: Article

References (25)

1. Franco V, Florena AM, Iannitto E. Splenic marginal zone lymphoma. Blood. 2003;101:2464-2472.
2. Troussard X, Valensi F, Duchayne E, et al. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Br J Haematol 1996;93:731-736.
3. Chacòn JI, Mollejo M, Muñoz E, et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood. 2002;100:1648-1654.
4. Catovsky D, Matutes E. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Semin Hematol. 1999;36:148-154.
5. Demopoulos A, DeAngelis L. Neurologic complications of leukemia. Curr Opin Neurol. 2002;15:691-699.
6. Morrison C, Shah S, Flinn IW. Leptomeningeal involvement in chronic lymphocytic leukemia. Cancer Pract. 1998;6:223-228.
7. Voght-Schaden M, Wildemann B, Stellejer M, Hans J, Storch-Hagenlocher B, Ginshach C. Leptomeningeal dissemination of chronic lymphatic leukemia: molecular genetic detection in cerebrospinal fluid [in German]. Nervenarzt. 1999;70:363-367.
8. Wang ML, Shih LY, Dunn P, Kuo MC. Meningeal involvement in B-cell chronic lymphocytic leukemia: report of two cases. J Formos Med Assoc. 2000;99:775-778.
9. Poltorak M, Czlonkowska A, Nowicka K. Chronic lymphocytic leukemia: study of cell subsets in cerebrospinal fluid and peripheral blood. Eur Neurol. 1983;22:289-292.
10. Miller K, Budke H, Orazi A. Leukemic meningitis complicating early stage chronic lymphocytic leukemia. Arch Pathol Lab Med. 1997;121:524-527.
11. Brick WG, Majmundat M, Hendricks K, Kallab AM, Burguess RE, Jilella AP. Leukemic leptomeningeal involvement in stage 0 and stage 1 chronic lymphocytic leukemia. Leuk Lymphoma. 2002;43:199-120.
12. Weizsaeker M, Koelmel HW. Meningeal involvement in leukemias and malignant lymphomas of adults: incidence, course of disease, and treatment for prevention. Acta Neurol Scand. 1979;60:363-370.
13. Navarrete D, Bodega E. Leukemic meningitis in a patient with hairy cell leukemia: a case report. Nouv Rev Fr Hematol. 1987;29:247-249.
14. Knecht H, Budmiger H, Groscurth P, Streuli RA. Central nervous system involvement in hairy cell leukemia. Klin Wochenschr. 1985;63:423-427.
15. Wolfe DW, Scopelliti JA, Boselli BD. Leukemic meningitis in a patient with hairy cell leukemia: a case report. Cancer. 1984;54:1085-1087.
16. Bilgrami S, Shafi N, Pesanti EL, et al. Mantle-cell lymphoma in a patient with human immunodeficiency viral infection. Acta Haematol. 1995;93:101-104.
17. Lunning MA, Stetler-Stevenson M, Silverstein PT, Zenger V, Marti GE. Spontaneous (pathological) splenic rupture in a blastic variant of mantle cell lymphoma: a case report and literature review. Clin Lymphoma. 2002;3:117-120.
18. Gotlib V, Singareddy S, Gergis U, et al. Leptomeningeal involvement in a patient with splenic lymphoma with villous lymphocytes. Leuk Lymphoma. 2002;43:1337-1340.
19. Yamazaki K, Shimizu S, Negami T, et al. Leukemic meningitis in a patient with splenic lymphoma with villous lymphocytes (SLVL). Cancer. 1994;73:61-65.
20. Marmont AM. Leukemic meningitis in B-cell chronic lymphocytic leukemia: resolution following intrathecal methotrexate. Blood. 2000;9:776-777.
21. De Rossi G, Zarcone D, Muro F, et al. Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: malignant cell phenotypes define distinct disease subsets. Blood. 1993;81:2679-2687.
22. Csanaky G, Matutes E, Vass JA, Monilla R, Catovsky D. Adhesion receptors on peripheral blood leukemic B cells: a comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia. 1997;11:408-415.
23. Strazielle N, Ghersi-Egea JF. Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol. 2000;59:561-574.
24. Steffen BJ, Breier G, Butcher EC, Schulz M, Engelhardt B. ICAM-1, VCAM-1 and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol. 1996;148:1819-1838.
25. Baehring JM, Damek D, Martin EC, Batensky RB, Hochberg FH. Neurolymphomatosis. Neuro-Oncol. 2003;5:104-115.